After virological breakthrough, the actuarial probability of maintaining biochemical remission diminished to 15% at 24 months and 0% at 29 months.
发生病毒突变后,24个月时实际产生持续生化学缓解的比率减低到15%,到29个月时为0%。
After virological breakthrough, the actuarial probability of maintaining biochemical remission diminished to 15% at 24 months and 0% at 29 months.
发生病毒突变后,24个月时实际产生持续生化学缓解的比率减低到15%,到29个月时为0%。
应用推荐